Medacta Gains FDA Clearance, Announces First U.S. Procedure for Hip Implants

Medacta received FDA 510(k) clearance to market its Mpact 3D Metal implant and Augments 3D Metal for use in total hip arthroplasties or revision procedures.

The company subsequently announced completion of the first U.S. procedure with the implants and augments.

Mpact 3D Metal Acetabular Two-Hole and Multi-Hole implants are enhancements to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us